Natco Pharma Ltd’s net profit increased 32 per cent at ₹30 crore in the third quarter of the current financial year ended December 31, 2013 compared with ₹22.6 crore in the corresponding quarter of the previous year.
The total revenue of the Hyderabad-based company increased 14.5 per cent at ₹203 crore (₹177 crore). The growth was driven by a significant growth in formulations, among others. The earnings per share stood at ₹9.34 as against ₹7.20 in the year-ago period.
Natco’s scrip lost 3.14 per cent to end at ₹743.80 on the Bombay Stock Exchange on Thursday.
No comments:
Post a Comment